HERZLIYA, Israel and CALGARY, Alberta, Nov. 24, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, proudly announces the publication of a research article titled...
Hence then, the article about innocan pharma announces promising translational evidence from a pain relief study of repeated lpt cbd administration in goats was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats )
Also on site :
- Divorce, smartphones and control - BBC sees how Taliban run Afghanistan
- Quote of the Day: Stoic Philosopher Zeno of Citium on Why Listening May Be More Powerful Than Speaking
- Trump's 'economic D-Day' on Iran puts China in the crosshairs